Patents by Inventor Dieter Cullmann

Dieter Cullmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11000575
    Abstract: The present invention relates to the use of hyaluronidase for the prevention and/or treatment of cardiac insufficiency. In addition, the present invention provides a composition and a combined preparation each comprising hyaluronidase and at least one further antihypertensive, and a method of prevention and/or treating cardiac insufficiency in a patient in need thereof, wherein the patient is administered a therapeutically effective amount of hyaluronidase.
    Type: Grant
    Filed: September 28, 2018
    Date of Patent: May 11, 2021
    Assignee: Pantarhin Pharma LLC
    Inventors: Dieter Cullmann, Gunther Burgard
  • Publication number: 20190091302
    Abstract: The present invention relates to the use of hyaluronidase for the prevention and/or treatment of arterial hypertension or cardiac insufficiency. In addition, the present invention provides a composition and a combined preparation each comprising hyaluronidase and at least one further antihypertensive, and a method of prevention and/or treating arterial hypertension or cardiac insufficiency in a patient in need thereof, wherein the patient is administered a therapeutically effective amount of hyaluronidase.
    Type: Application
    Filed: September 28, 2018
    Publication date: March 28, 2019
    Inventors: Dieter Cullmann, Gunther Burgard
  • Patent number: 10086051
    Abstract: The present invention relates to the use of hyaluronidase for the prevention and/or treatment of arterial hypertension or cardiac insufficiency. In addition, the present invention provides a composition and a combined preparation each comprising hyaluronidase and at least one further antihypertensive, and a method of prevention and/or treating arterial hypertension or cardiac insufficiency in a patient in need thereof, wherein the patient is administered a therapeutically effective amount of hyaluronidase.
    Type: Grant
    Filed: October 13, 2009
    Date of Patent: October 2, 2018
    Assignee: PANTARHIN PHARMA LLC
    Inventors: Dieter Cullmann, Gunther Burgard
  • Publication number: 20100092450
    Abstract: The present invention relates to the use of hyaluronidase for the prevention and/or treatment of arterial hypertension or cardiac insufficiency. In addition, the present invention provides a composition and a combined preparation each comprising hyaluronidase and at least one further antihypertensive, and a method of prevention and/or treating arterial hypertension or cardiac insufficiency in a patient in need thereof, wherein the patient is administered a therapeutically effective amount of hyaluronidase.
    Type: Application
    Filed: October 13, 2009
    Publication date: April 15, 2010
    Inventors: Dieter Cullmann, Gunther Burgard
  • Publication number: 20080124316
    Abstract: The invention relates to use of the enzyme hyaluronidase in a dosage of at least 6,000 units per day for prevention and/or treatment of cardiovascular diseases whereby the hyaluronidase is administered intra venam over a period of at least four weeks. Hyaluronidase is particularly suited to treating coronary heart diseases as well as for preventive purposes in patients at risk of heart infarctions.
    Type: Application
    Filed: January 31, 2008
    Publication date: May 29, 2008
    Inventors: Gunther BURGARD, Heinz Dieter CULLMANN